Buffalo-based Athenex, Inc. focuses on drug discovery, development, and commercialization for cancer treatment. With its Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform, the company's pipeline includes products like Oral paclitaxel and encequidar, Tirbanibulin ointments, and KUR-501. It boasts a portfolio of TCRs that target multiple tumors, and is developing dual absorption enhancers to inhibit P-gp transporter and cytochrome p450 3A enzymes.